Evidence map›Paper›PMID 30952903›Full record

ArticleScientific reports2019

High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells.

Šárka Šimečková, Zuzana Kahounová, Radek Fedr, Ján Remšík, Eva Slabáková, Tereza Suchánková, Jiřina Procházková, Jan Bouchal, Gvantsa Kharaishvili, Milan Král and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Šárka ŠimečkováDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
Zuzana KahounováDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
Radek FedrDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
Ján RemšíkDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
Eva SlabákováDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
Tereza SuchánkováDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
Jiřina ProcházkováDepartment of Chemistry and Toxicology, Veterinary Research Institute, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-2738-8546
Jan BouchalDepartment of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.ORCID http://orcid.org/0000-0003-4842-1720
Gvantsa KharaishviliDepartment of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
Milan KrálDepartment of Urology, University Hospital, Olomouc, Czech Republic.ORCID http://orcid.org/0000-0003-1851-5179
Petr BenešCenter of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne´s University Hospital Brno, Brno, Czech Republic.
Karel SoučekDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. ksoucek@ibp.cz.ORCID http://orcid.org/0000-0001-7283-8150
Czech Academy of Sciences, Institute of Biophysics · CZInstitute of Molecular and Translational Medicine · CZMasaryk University · CZCzech Academy of Sciences · CZMemorial Sloan Kettering Cancer Center · USUniversity Hospital Olomouc · CZVeterinary Research Institute · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skp2 is a crucial component of SCF

Indexed as

Epithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticAnimalsCD24 AntigenCell Line, TumorHumansHyaluronan ReceptorsMaleMiceMice, NudeNeoplasm GradingNeoplastic Stem CellsPC-3 CellsProstatic NeoplasmsS-Phase Kinase-Associated ProteinsXenograft Model Antitumor AssaysCD24 AntigenCD24 protein, humanCD44 protein, humanHyaluronan ReceptorsSKP2 protein, humanS-Phase Kinase-Associated Proteins

Identifiers

PMID30952903
PMCPMC6451010
OpenAlexW2933655530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.